The Enterprise Value as of November 2024 (TTM) for ABVC BioPharma, Inc. (ABVC) is 9.84M

According to ABVC BioPharma, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 9.84M. This represents a change of -12.06% compared to the average of 11.18M of the last 4 quarters.

ABVC BioPharma, Inc. (ABVC) Historical Enterprise Value (quarterly & annually)

How has ABVC Enterprise Value performed in the past?

The mean historical Enterprise Value of ABVC BioPharma, Inc. over the last ten years is 128.99M. The current 9.84M Enterprise Value has changed 662.54% with respect to the historical average. Over the past ten years (40 quarters), ABVC's Enterprise Value was at its highest in in the September 2015 quarter at 1.50B. The Enterprise Value was at its lowest in in the June 2015 quarter at 222.57K.

ABVC BioPharma, Inc. (ABVC) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of ABVC BioPharma, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

ABVC BioPharma, Inc. (ABVC) Average Enterprise Value

How has ABVC Enterprise Value performed in the past?

The current Enterprise Value of ABVC BioPharma, Inc. (ABVC) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

ABVC BioPharma, Inc. (ABVC) Enterprise Value vs. Peers

How is ABVC’s Enterprise Value compared to its peers?

ABVC BioPharma, Inc.’s Enterprise Value is greater than Indaptus Therapeutics, Inc. (4.76M), greater than Pasithea Therapeutics Corp. (-4187996.00), greater than Better Therapeutics, Inc. (7.71M), greater than Forte Biosciences, Inc. (-3195101.00), less than Evelo Biosciences, Inc. (16.69M), greater than Aptinyx Inc. (-13266343.00), greater than Magenta Therapeutics, Inc. (-114170976.00), less than Aileron Therapeutics, Inc. (64.72M), greater than Aridis Pharmaceuticals, Inc. (1.40M), less than Akari Therapeutics, Plc (26.33M), less than Aditxt, Inc. (12.23M), less than Acasti Pharma Inc. (14.78M), less than RenovoRx, Inc. (13.20M), less than Anebulo Pharmaceuticals, Inc. (45.92M), less than SAB Biotherapeutics, Inc. (25.39M), less than Monopar Therapeutics Inc. (81.10M), less than Eledon Pharmaceuticals, Inc. (254.81M), less than Nutriband Inc. (57.98M), greater than Quoin Pharmaceuticals, Ltd. (3.24M), less than Longeveron Inc. (20.39M), greater than Virax Biolabs Group Limited (5.49M),

Build a custom stock screener for ABVC BioPharma, Inc. (ABVC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ABVC BioPharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ABVC BioPharma, Inc. (ABVC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ABVC BioPharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.